New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies

ConditionBK Virus Infection

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity Hospital, Strasbourg, France

About this trial

BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.

Eligibility criteria

Qualifiers

BK positive

adult

ok to participed to research

Disqualifiers

under guardianship

under curatorship

opposed to research

deprived of liberty

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University Hospital, Strasbourg, France

Lead sponsor

Source ClinicalTrials.gov